Adaptimmune Therapeutics Statistics

Total Valuation

ADAP has a market cap or net worth of $77.53 million. The enterprise value is $66.67 million.

Market Cap	77.53M
Enterprise Value	66.67M

Important Dates

The last earnings date was Tuesday, May 13, 2025, before market open.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ADAP has 265.05 million shares outstanding. The number of shares has increased by 16.28% in one year.

Current Share Class	n/a
Shares Outstanding	265.05M
Shares Change (YoY)	+16.28%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	10.88%
Float	174.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.42
Forward PS	2.52
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.02

Current Ratio	2.02
Quick Ratio	1.57
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9.03

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-14.19%
Return on Invested Capital (ROIC)	-99.46%
Return on Capital Employed (ROCE)	-44.13%
Revenue Per Employee	$355,018
Profits Per Employee	-$138,132
Employee Count	506
Asset Turnover	0.86
Inventory Turnover	21.40

Taxes

In the past 12 months, ADAP has paid $3.63 million in taxes.

Income Tax	3.63M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.04% in the last 52 weeks. The beta is 2.85, so ADAP's price volatility has been higher than the market average.

Beta (5Y)	2.85
52-Week Price Change	-71.04%
50-Day Moving Average	0.27
200-Day Moving Average	0.63
Relative Strength Index (RSI)	53.91
Average Volume (20 Days)	1,621,339

Short Selling Information

Short Interest	5.83M
Short Previous Month	4.45M
Short % of Shares Out	2.67%
Short % of Float	n/a
Short Ratio (days to cover)	3.44

Income Statement

In the last 12 months, ADAP had revenue of $179.64 million and -$69.90 million in losses. Loss per share was -$0.29.

Revenue	179.64M
Gross Profit	35.98M
Operating Income	-47.22M
Pretax Income	-162.17M
Net Income	-69.90M
EBITDA	-36.36M
EBIT	-47.22M
Loss Per Share	-$0.29

Full Income Statement

Balance Sheet

The company has $59.56 million in cash and $48.71 million in debt, giving a net cash position of $10.86 million or $0.04 per share.

Cash & Cash Equivalents	59.56M
Total Debt	48.71M
Net Cash	10.86M
Net Cash Per Share	$0.04
Equity (Book Value)	-37.43M
Book Value Per Share	-0.15
Working Capital	51.93M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$107.85 million and capital expenditures -$1.99 million, giving a free cash flow of -$109.84 million.

Operating Cash Flow	-107.85M
Capital Expenditures	-1.99M
Free Cash Flow	-109.84M
FCF Per Share	-$0.41

Full Cash Flow Statement

Margins

Gross margin is 20.03%, with operating and profit margins of -26.29% and -38.91%.

Gross Margin	20.03%
Operating Margin	-26.29%
Pretax Margin	-36.89%
Profit Margin	-38.91%
EBITDA Margin	-20.24%
EBIT Margin	-26.29%
FCF Margin	n/a

Dividends & Yields

ADAP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.28%
Shareholder Yield	-16.28%
Earnings Yield	-90.16%
FCF Yield	-141.67%

Analyst Forecast

The average price target for ADAP is $1.52, which is 419.66% higher than the current price. The consensus rating is "Buy".

Price Target	$1.52
Price Target Difference	419.66%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	7.39%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ADAP has an Altman Z-Score of -8.88 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.88
Piotroski F-Score	2